[title missed]

Corresponding author: ZhangTing, 982409509@qq.com

DOI: 10.12201/bmr.202610.00067

•  

  Abstract: [abstract missed]

  Key words: ; ; ; 

  Submit time: 29 October 2026

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• wangyixuan, wusiyi, fangyue, zhoulushan, songxiaobo, leilei, chenxiaofei, dingcaifei, wangchenye. . 2024. doi: 10.12201/bmr.202407.00047

  LI Xiao, YAO Hongmei. Ovarian steroid cell tumor with polycystic ovary syndrome：a case report. 2025. doi: 10.12201/bmr.202505.00034

  Zhang Han, Chu Mengyuan, Xu Kaikai, Xiang Xin, Yan Ying. Progress in Mechanism of Action of Isthmin1 Protein in Polycystic Ovary Syndrome. 2024. doi: 10.12201/bmr.202411.00004

  Zhang Ting. . 2024. doi: 10.12201/bmr.202412.00088

  Zhang Bo, Zhu Ying, Chen Zheng. . 2025. doi: 10.12201/bmr.202511.00006

  SuZhuang. . 2026. doi: 10.12201/bmr.202604.00042

  CHU Tong, XIAO Xi, WANG Peijuan. Research Progress on the Core Metabolic Pathological Mechanisms and Treatment Strategies of Polycystic Ovary Syndrome. 2025. doi: 10.12201/bmr.202512.00007

  Liu Lingyan. Ferroptosis and endoplasmic reticulum stress in polycystic ovary syndrome and related potential therapeutic targets. 2025. doi: 10.12201/bmr.202507.00042

  何梦凡, LU Xueling, Cao Yujie. Advances in Glucagon-Like Peptide-1 Receptor Agonists for Metabolic Treatment of Polycystic Ovary Syndrome. 2026. doi: 10.12201/bmr.202608.00002

• ID	Submit time	Number	Download
  1	2026-09-06	10.12201/bmr.202610.00067V1	Download

• Public  Anonymous  To author only Submit Comments